THE EFFICACY AND SAFETY OF SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
作者：
Alves, C. [1 ,2 ]
Penedones, A. [1 ]
Mendes, D. [1 ,2 ]
Batel Marques, F. [1 ,2 ]
机构：
[1] AIBILI Assoc Innovat & Biomed Res Light & Image, CHAD Ctr Hlth Technol Assessment & Drug Res, Coimbra, Portugal
[2] Univ Coimbra, Sch Pharm, Coimbra, Portugal
来源：
CLINICAL THERAPEUTICS | 2015年 / 37卷 / 08期
关键词：
D O I：
10.1016/j.clinthera.2015.05.352
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E123 / E124
页数：2
相关论文
共 50 条
[21]   Sodium-glucose cotransporter 2 (SGLT2) inhibitors and fracture risk in patients with type 2 diabetes mellitus: A meta-analysis [J].
Ruanpeng, Darin ;
Ungprasert, Patompong ;
Sangtian, Jutarat ;
Harindhanavudhi, Tasma .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (06)
[22]   Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease: a systematic review and meta-analysis [J].
Shiau, Chu-Hsuan ;
Tsau, Li-Yun ;
Kao, Chih-Chin ;
Peng, Yu-Ching ;
Bai, Chyi-Huey ;
Wu, Jeng-Cheng ;
Hou, Wen-Hsuan .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (04) :1359-1381
[23]   Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease: a systematic review and meta-analysis [J].
Chu-Hsuan Shiau ;
Li-Yun Tsau ;
Chih-Chin Kao ;
Yu-Ching Peng ;
Chyi-Huey Bai ;
Jeng‑Cheng Wu ;
Wen-Hsuan Hou .
International Urology and Nephrology, 2024, 56 :1359-1381
[24]   The Safety and Efficacy of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Acute Myocardial Infarction: A Systematic Review and MetaAnalysis of Randomized Controlled Trials [J].
Jafar, Uzair ;
Khan, Muhammad Sami ;
Hashmi, Tallal Mushtaq ;
Ijaz, Maryam ;
Jehangir, Hanzala ;
Jagani, Sanjna Devi ;
Munawar, Irja ;
Khalid, Ayesha ;
Maqsood, Maham ;
Akram, Muhammad Faiq ;
Saeed, Usman ;
Ahmad, Adeel .
CIRCULATION, 2024, 150
[25]   Bexagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, for improvement of glycemia in type 2 diabetes mellitus: a systematic review and meta-analysis [J].
Dholariya, Sagar ;
Dutta, Siddhartha ;
Singh, Ragini ;
Parchwani, Deepak ;
Sonagra, Amit ;
Kaliya, Mehul .
EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) :2187-2198
[26]   Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis [J].
Donnan, Jennifer R. ;
Grandy, Catherine A. ;
Chibrikov, Eugene ;
Marra, Carlo A. ;
Aubrey-Bassler, Kris ;
Johnston, Karissa ;
Swab, Michelle ;
Hache, Jenna ;
Curnew, Daniel ;
Hai Nguyen ;
Gamble, John-Michael .
BMJ OPEN, 2019, 9 (01)
[27]   Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis [J].
Butler, Javed ;
Usman, Muhammad Shariq ;
Khan, Muhammad Shahzeb ;
Greene, Stephen J. ;
Friede, Tim ;
Vaduganathan, Muthiah ;
Filippatos, Gerasimos ;
Coats, Andrew J. Stewart ;
Anker, Stefan D. .
ESC HEART FAILURE, 2020, 7 (06) :3298-3309
[28]   Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk [J].
Jasleen, Bains ;
Vishal, Gupta K. ;
Sameera, Malepati ;
Fahad, Molla ;
Brendan, O'Brien ;
Deion, Santander ;
Pemminati, Sudhakar .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
[29]   REVIEW OF EFFICACY AND SHORT TERM SAFETY OF SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS USE IN DIABETIC RENAL TRANSPLANT RECIPIENTS [J].
AlKindi, Fatima ;
Chaaban, Ahmad ;
AlHakim, Mohammed ;
Hussain, Qutaiba ;
Boobes, Yousef .
TRANSPLANTATION, 2020, 104 (09) :S384-S384
[30]   Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits? [J].
Andreea, Munteanu Madalina ;
Surabhi, Swarnkar ;
Razvan-Ionut, Popescu ;
Lucia, Ciobotaru ;
Camelia, Nicolae ;
Emil, Tufanoiu ;
Tiberiu, Nanea Ioan .
MEDICINA-LITHUANIA, 2023, 59 (04)
12345